🇰🇷 Drospirenone Ethinyl estradiol in South Korea

Drospirenone Ethinyl estradiol (Drospirenone Ethinyl estradiol) regulatory status in South Korea.

Marketing authorisations

MFDS

Status: likely_approved

MFDS

Status: likely_approved

MFDS

Status: likely_approved

MFDS

Status: likely_approved

Drospirenone Ethinyl estradiol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇦🇪 United Arab Emirates
AR
🇦🇺 Australia
🇧🇷 Brazil
🇨🇦 Canada
CO
🇬🇧 United Kingdom
HK
🇮🇱 Israel
🇮🇳 India
🇲🇽 Mexico
MY
PH
🇸🇬 Singapore
TH
TR
TW
🇺🇸 United States
ZA

Frequently asked questions

Is Drospirenone Ethinyl estradiol approved in South Korea?

Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.

Who is the marketing authorisation holder for Drospirenone Ethinyl estradiol in South Korea?

AGUNCO Obstetrics and Gynecology Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.